Previous Page  20 / 23 Next Page
Information
Show Menu
Previous Page 20 / 23 Next Page
Page Background

Page 64

Journal of Medical Physics and Applied Sciences

ISSN: 2574-285X

I n t e r n a t i o n a l C o n f e r e n c e o n

Nuclear Medicine &

Radiation Therapy

Nuclear Medicine & Radiation Therapy 2018

O c t o b e r 0 1 - 0 2 , 2 0 1 8

S t o c k h o l m , S w e d e n

W

e present the development and characterization of a [

99

mTc] tricarbonyl urea. Labelling with high yield and radiochemical

purity was achieved through the formation of a [

99

mTc] tricarbonyl urea radiotracer. The radiolabeled compound was

stable and exhibited plasma protein binding (approximately 40%). The logarithm of the partition coefficient (log p) value of

[

99

mTc] tricarbonyl urea was -2.55±0.17 (hydrophilic). Bio-distribution studies in normal mice confirmed the suitability of [

99

mTc]

tricarbonyl urea as a novel tracer to image kidneys. [

99

mTc] tricarbonyl urea could be considered a new selective radiotracer for

kidneys imaging.

drsanad74@gmail.com

Synthesis, labelling and preliminary

bioevaluation of 99mTc-urea as a potential

kidneys imaging agent

M H Sanad

1

and Dina H Salama

2

1

Egyptian Atomic Energy Authority (EAEA)-HLWMC, Egypt

2

National Center for Radiation Research and Technology-AEA, Egypt

J. med phys & appl sci 2018, Volume: 3

DOI: 10.21767/2574-285X-C1-003